Palisade Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-328,508
Closed -$5.58M 544
2016
Q1
$5.58M Sell
328,508
-156,880
-32% -$2.62M 0.18% 177
2015
Q4
$9.94M Sell
485,388
-263,636
-35% -$5.49M 0.32% 103
2015
Q3
$16.1M Sell
749,024
-647,820
-46% -$14.5M 0.47% 45
2015
Q2
$27.9M Sell
1,396,844
-973,952
-41% -$17.1M 0.71% 14
2015
Q1
$36.9M Sell
2,370,796
-382,060
-14% -$5.77M 0.93% 7
2014
Q4
$37.9M Buy
2,752,856
+50,484
+2% +$618K 0.92% 9
2014
Q3
$27M Sell
2,702,372
-199,936
-7% -$2.04M 0.68% 15
2014
Q2
$28.8M Sell
2,902,308
-169,588
-6% -$1.5M 0.7% 12
2014
Q1
$31.8M Sell
3,071,896
-157,956
-5% -$1.63M 0.78% 12
2013
Q4
$28.6M Sell
3,229,852
-36,256
-1% -$287K 0.74% 14
2013
Q3
$23M Sell
3,266,108
-1,229,324
-27% -$7.79M 0.63% 27
2013
Q2
$25.2M Buy
+4,495,432
New +$21.5M 0.73% 11

Other funds holding DXCM

Palisade Capital Management's DXCM Position: Q2 2016 in Review

Palisade Capital Management sold out of DexCom (DXCM) in Q2 2016, closing a stake of 328,508 shares — an estimated $5.58M sold.

Palisade Capital Management first reported a position in DXCM in Q2 2013 and held it in 12 quarters. The position peaked at $37.9M in Q4 2014. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2016.

  • Palisade Capital Management reported no remaining DexCom position as of Q2 2016 after selling out during the quarter.
  • Palisade Capital Management sold 328,508 DexCom shares in Q2 2016, an estimated $5.58M.
  • Palisade Capital Management first reported a position in DexCom in Q2 2013 and held it in 12 quarters.
  • Palisade Capital Management's DexCom position peaked at $37.9M in Q4 2014.
  • 279 funds tracked by Wall St. Rank held DexCom as of Q2 2016.

Based on Palisade Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.